Journal of Adolescent Health
Volume 30, Issue 4, Supplement 1 , Pages 37-43 , April 2002

Autoimmunity, dehydroepiandrosterone (DHEA), and stress

  • Kenneth E Schwartz, M.D.

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Kenneth E. Schwartz, M.D., Genelabs Technologies, Inc., 505 Penobscot Drive, Redwood City, CA 94063 USA
    • Genelabs Technologies, Inc., Redwood City, California, USA
    • Dr. Schwartz is an employee of Genelabs Technologies, Inc. which is sponsoring clinical trials on the use of oral prasterone (DHEA) for treatment of systemic lupus erythematosus.

,Accepted 14 September 2001.

References 

  1. De Peretti E, Forest MG. Unconjugated dehydroepiandrosterone plasma levels in normal subjects from birth to adolescence in human (The use of a sensitive radioimmunoassay). J Clin Endocrinol Metab. 1976;43:982–991
  2. Parker LN. Control of adrenal androgen secretion. Endocrinol Metab Clin North Am. 1991;20:401–421
  3. Gell JS, Carr BR, Sasano H, et al.  Adrenarche results from development of a 3beta-hydroxysteroid dehydrogenase-deficient adrenal reticularis. J Clin Endocrinol Metab. 1998;83:3695–3701
  4. Nakajin S, Shively JE, Yuan PM, et al.  Microsomal cytochrome P-450 from neonatal pig testis (Two enzymatic activities (17 alpha-hydroxylase and c17,20-lyase) associated with one protein). Biochemistry. 1981;20:4037–4042
  5. Geller DH, Auchus RJ, Mendonca BB, et al.  The genetic and functional basis of isolated 17,20-lyase deficiency. Nat Genet. 1997;17:201–205
  6. Miller WL. Early steps in androgen biosynthesis (From cholesterol to DHEA). Bailliere’s Clin Endocrinol Metab. 1998;12:67–81
  7. Garcia-Mayor RV, Andrade MA, Rios M, et al.  Serum leptin levels in normal children (Relationship to age, gender, body mass index, pituitary-gonadal hormones, and pubertal state). J Clin Endocrinol Metab. 1997;82:2849–2855
  8. Blum WF, Englaro P, Hanitsch S, et al.  Plasma leptin levels in healthy children and adolescents (Dependence on body mass index, body fat mass, gender, pubertal state, and testosterone). J Clin Endocrinol Metab. 1997;82:2904–2910
  9. Cizza G, Dorn LD, Lotsikas A, et al.  Circulating plasma leptin and IGF-1 levels in girls with premature adrenarche (Potential implications of a preliminary study). Horm Metab Res. 2001;33:138–143
  10. Milewich L, Garcia RL, Gerrity LW. Steroid sulfatase and 17β-hydroxysteroid oxidoreductase activities in mouse tissues. J Steroid Biochem. 1984;21:529–538
  11. Liu CH, Laughlin GA, Fischer UG, et al.  Marked attenuation of ultradian and circadian rhythms of dehydroepiandrosterone in postmenopausal women (Evidence for a reduced 17,20-desmolase enzymatic activity). J Clin Endocrinol Metab. 1990;71:900–906
  12. Pavlov EP, Harman SM, Chrousos GP, et al.  Responses of plasma adrenocorticotropin, cortisol, and dehydroepiandrosterone to ovine corticotropin-releasing hormone in healthy aging men. J Clin Endocrinol Metab. 1986;62:767–772
  13. Rotter JI, Wong FL, Lifrak ET, et al.  A genetic component to the variation of dehydroepiandrosterone sulfate. Metabolism. 1985;34:731–736
  14. Parker LN, Levin ER, Lifrak ET. Evidence for adrenocortical adaptation to severe illness. J Clin Endocrinol Metab. 1985;60:947–952
  15. Zipser RD, Davenport MW, Martin KL, et al.  Hyperreninemic hypoaldosteronism in the critically ill (A new entity). J Clin Endocrinol Metab. 1981;53:867–873
  16. Labrie F, Belanger A, Simard J, et al.  DHEA and peripheral androgen and estrogen formation (Intracinology). Ann N Y Acad Sci. 1995;774:16–28
  17. Grodin JM, Siiteri PK, MacDonald PC. Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab. 1973;36:207–214
  18. Beeson PB. Age and sex associations of 40 autoimmune diseases. Am J Med. 1994;96:457–462
  19. Olsen NJ, Kovacs WJ. Gonadal steroids and immunity. Endocr Rev. 1996;17:369–384
  20. Lockshin MD. Why women?. Lupus. 1997;6:625–632
  21. Wallace DJ. The clinical presentation of systemic lupus erythematosus. In:  Wallace DJ,  Hahn B editor. Dubois’ Lupus Erythematosus. 5th edition.. Baltimore, MD: Williams & Wilkins; 1997;p. 627–633
  22. Mund A, Simson J, Rothfield N. Effect of pregnancy on the course of SLE. JAMA. 1963;183:917–920
  23. Petri M. Systemic lupus erythematosus and pregnancy. Rheum Dis Clin North Am. 1994;20:87–118
  24. Urowitz MB, Gladman DD, Farewell VT, et al.  Lupus and pregnancy studies. Arthritis Rheum. 1993;36:1392–1397
  25. Roubinian JR, Papoian R, Talal N. Androgenic hormones modulate autoantibody responses and improve survival in murine lupus. J Clin Invest. 1977;59:1066–1070
  26. Lucas JA, Ahmed SA, Casey ML, et al.  Prevention of autoantibody formation and prolonged survival in New Zealand black/New Zealand white F1 mice fed dehydroisoandrosterone. J Clin Invest. 1985;75:2091–2093
  27. Bizzarro A, Valentini G, Di Martino G, et al.  Influence of testosterone therapy on clinical and immunological features of autoimmune diseases associated with Klinefelter’s syndrome. J Clin Endocrinol Metab. 1987;64:32–36
  28. Olsen NJ, Kovacs WJ. Case report (Testosterone treatment of systemic lupus erythematosus in a patient with Klinefelter’s syndrome). Am J Med Sci. 1995;310:158–160
  29. Wofsy D, Murphy ED, Roths JB, et al.  Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene. J Exp Med. 1981;154:1671–1680
  30. Daynes RA, Dudley DJ, Araneo BA. Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells. Eur J Immunol. 1990;20:793–802
  31. Alcocer-Varela J, Alarcon-Segovia D. Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J Clin Invest. 1982;69:1388–1392
  32. Linker-Israeli M, Bakke AC, Kitridou RC, et al.  Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J Immunol. 1983;130:2651–2655
  33. Suzuki T, Suzuki N, Daynes RA, et al.  Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. Clin Immunol Immunopathol. 1991;61:202–211
  34. Lahita RG, Bradlow HL, Kunkel HG, et al.  Alterations of estrogen metabolism in systemic lupus erythematosus. Arthritis Rheum. 1979;22:1195–1198
  35. Lahita RG, Bradlow HL, Kunkel HG, et al.  Increased 16 alpha-hydroxylation of estradiol in systemic lupus erythematosus. J Clin Endocrinol Metab. 1981;53:174–178
  36. Lahita RG, Bradlow HL, Fishman J, et al.  Estrogen metabolism in systemic lupus erythematosus (Patients and family members). Arthritis Rheum. 1982;25:843–856
  37. Zhu BT, Conney AH. Review (Functional role of estrogen metabolism in target cells: Review and perspectives). Carcinogenesis. 1998;19:1–27
  38. Fishman J, Martucci C. Biological properties of 16 alpha-hydroxyestrone (Implications in estrogen physiology and pathophysiology). J Clin Endocrinol Metab. 1980;51:611–615
  39. Bucala R, Fishman J, Cerami A. Formation of covalent adducts between cortisol and 16 alpha-hydroxyestrone and protein (Possible role in the pathogenesis of cortisol toxicity and systemic lupus erythematosus). Proc Natl Acad Sci. 1982;79:3320–3324
  40. Lahita RG, Bradlow HL. Klinefelter’s syndrome (Hormone metabolism in hypogonadal males with systemic lupus erythematosus). J Rheumatol. 1987;14(Suppl 13):154–157
  41. Lamberts SW, Verleun T, Hofland L, et al.  Differences in the interaction between dopamine and estradiol on prolactin release by cultured normal and tumorous human pituitary cells. J Clin Endocrinol Metab. 1986;63:1342–1347
  42. Shupnik MA, Pitt LK, Soh AY, et al.  Selective expression of estrogen receptor alpha and beta isoforms in human pituitary tumors. J Clin Endocrinol Metab. 1998;83:3965–3972
  43. Fishman J, Tulchinsky D. Suppression of prolactin secretion in normal young women by 2-hydroxyestrone. Science. 1980;210:73–74
  44. Sabharwal P, Glaser R, Lafuse W, et al.  Prolactin synthesized and secreted by human peripheral blood mononuclear cells (An autocrine growth factor for lymphoproliferation). Proc Natl Acad Sci. 1992;89:7713–7716
  45. Hiestand PC, Mekler P, Nordmann R, et al.  Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine. Proc Natl Acad Sci. 1986;83:2599–2603
  46. Jara LJ, Lavalle C, Espinoza LR. Does prolactin have a role in the pathogenesis of systemic lupus erythematosus?. J Rheumatol. 1992;1:1333–1336
  47. Chikanza IC, Petrou P, Kingsley G, et al.  Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum. 1992;35:1281–1288
  48. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med. 1995;332:1351–1362
  49. Masi AT, Chrousos GP. Hypothalamic-pituitary-adrenal-glucocorticoid axis function in rheumatoid arthritis. J Rheumatol. 1996;23:577–581
  50. Cutolo M, Foppiani L, Prete C, et al.  Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids. J Rheumatol. 1999;26:282–288
  51. Crofford LJ, Kalogeras KT, Mastorakos G, et al.  Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones (Failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis). J Clin Endocrinol Metab. 1997;82:1279–1283
  52. Schlaghecke R, Kornely E, Wollenhaupt J, et al.  Glucocorticoid receptors in rheumatoid arthritis. Arthritis Rheum. 1992;35:740–744
  53. Masi AT, Josipovic DB, Jefferson WE. Low adrenal androgenic-anabolic steroids in women with rheumatoid arthritis (RA) (Gas-liquid chromatographic studies of RA patients and matched normal control women indicating decreased 11-deoxy-17-ketosteroid excretion). Semin Arthritis Rheum. 1984;14:1–23
  54. Cutolo M, Masi AT. Do androgens influence the pathophysiology of rheumatoid arthritis? Facts and hypotheses. J Rheumatol. 1998;25:1041–1047
  55. Masi AT, Chrousos GP, Bornstein SR. Enigmas of adrenal androgen and glucocorticoid dissociation in premenopausal onset rheumatoid arthritis. J Rheumatol. 1999;26:247–250
  56. Ehrhart-Bornstein M, Hinson JP, Bornstein SR, et al.  Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev. 1998;19:101–143
  57. Nussdorfer GG, Mazzocchi G. Immune-endocrine interactions in the mammalian adrenal gland (Facts and hypotheses). Int Rev Cytol. 1998;183:143–184
  58. Reichlin S. Neuroendocrine-immune interactions. N Engl J Med. 1993;329:1246–1253
  59. Hennebold JD, Daynes RA. Regulation of macrophage dehydroepiandrosterone sulfate metabolism by inflammatory cytokines. Endocrinology. 1994;135:67–75
  60. Straub RH, Konecna L, Hrach S, et al.  Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro (Possible link between endocrinosenescence and immunosenescence). J Clin Endocrinol Metab. 1998;83:2012–2017
  61. Kimura M, Tanaka S, Yamada Y, et al.  Dehydroepiandrosterone decreases serum tumor necrosis factor-alpha and restores insulin sensitivity (Independent effect from secondary weight reduction in genetically obese Zucker fatty rats). Endocrinology. 1998;139:3249–3253
  62. Padgett DA, Loria RM. Endocrine regulation of murine macrophage function (Effects of dehydroepiandrosterone, androstenediol, and androstenetriol). J Neuroimmunol. 1998;84:61–68
  63. Cutolo M, Accardo S, Villaggio , et al.  Androgen and estrogen receptors are present in primary cultures of human synovial macrophages. J Clin Endocrinol Metab. 1996;81:8320–8327
  64. Vaishnaw AK, McNally JD, Elkon KB. Apoptosis in the rheumatic diseases. Arthritis Rheum. 1997;40:1917–1927
  65. Cutolo M, Sulli A, Barone A, et al.  Sex hormones, proto-oncogene expression and apoptosis (Their effects on rheumatoid synovial tissue). Clin Exp Rheumatol. 1996;14:87–94
  66. Seki M, Ushiyama C, Seta N, et al.  Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus. Arthritis Rheum. 1998;41:823–830
  67. Rosen A, Casciola-Rosen L. Autoantigens as substrates for apoptotic proteases (Implications for the pathogenesis of systemic autoimmune disease). Cell Death Differ. 1999;6:6–12
  68. Schwartzman RA, Cidlowski JA. Apoptosis (The biochemistry and molecular biology of programmed cell death). Endocr Rev. 1993;14:133–151
  69. Hedman M, Nilsson E, de la Torre B. Low blood and synovial fluid levels of sulpho-conjugated steroids in rheumatoid arthritis. Clin Exp Rheumatol. 1992;10:25–30
  70. van Vollenhoven RF, Engleman EG, McGuire JL. An open study of dehydroepiandrosterone in systemic lupus erythematosus. Arthritis Rheum. 1994;37:1305–1310
  71. van Vollenhoven RF, Engleman EG, McGuire JL. Dehydroepiandrosterone in systemic lupus erythematosus. Results of a double-blind, placebo-controlled, randomized clinical trial. Arthritis Rheum. 1995;38:1826–1831
  72. Petri M, Lahita R, McGuire J, et al.  Results of the GL701 (DHEA) Multicenter Steroid-Sparing SLE Study. abstract Arthritis Rheum. 1997;40(Suppl):S327

PII: S1054-139X(01)00385-8

Journal of Adolescent Health
Volume 30, Issue 4, Supplement 1 , Pages 37-43 , April 2002

Article Tools

* Image Usage & Resolution